相关实验视频

Updated: Jun 21, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K

基因组测试对泌尿科医生的治疗偏好在良好的风险前列腺癌的影响:一个随机试验

Samuel Carbunaru1, Zequn Sun2, Cordero McCall3

  • 1Department of Urology, New York University Langone School of Medicine, New York, New York, USA.

Cancer medicine
|October 3, 2023
PubMed
概括

基因组前列腺分数 (GPS) 测试显著增加了泌尿科医生对积极前列腺癌治疗的偏好,而不是积极监测. 这种生物标志物可能会影响有利风险患者的治疗决定.

关键词:
积极监督是指积极的监督.基因组学就是基因组学.前列腺癌是前列腺癌.治疗决定 治疗决定

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.6K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...